Brief: Aurobindo Pharma Says News On Co Being Frontrunner to Buy Orchid Pharma "Factually Incorrect"
Dec 18 (Reuters) - Aurobindo Pharma Ltd ARBN.NS :
* AUROBINDO PHARMA CLARIFIES ON NEWS ITEM, "AUROBINDO, DR
REDDY'S
LABORATORIES FRONTRUNNERS TO BUY OUT BANKRUPT ORCHID PHARMA"
* SAYS "DENY THE CONTENTS OF THE ABOVE MENTIONED NEWS AND
THEY
ARE FACTUALLY INCORRECT"
Source text for Eikon: ID:nBSE76Sghs
Further company coverage: ARBN.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices